NasdaqGS - Delayed Quote USD
CVRx, Inc. (CVRX)
4.7700
-3.0100
(-38.69%)
At close: May 9 at 4:00:01 PM EDT
4.9200
+0.15
+(3.14%)
After hours: May 9 at 7:45:32 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Kevin Hykes | President, CEO & Director | 940.13k | -- | 1966 |
| Mr. Jared Oasheim | Chief Financial Officer | 517.27k | -- | 1983 |
| Mr. Robert Allen John | Chief Revenue Officer | 535.88k | -- | 1973 |
| Mr. Paul Pignato | Vice President of Research, Development and Operations | -- | -- | -- |
| Ms. Jonelle R. Burnham | VP & General Counsel | -- | -- | 1971 |
| Mr. Paul Verrastro | Chief Marketing & Strategy Officer | 598.97k | -- | 1963 |
| Ms. Tonya A. Austin SPHR | Chief Human Resources Officer | -- | -- | 1972 |
| Dr. Philip B. Adamson M.D., M.Sc. | Chief Medical Officer | -- | -- | 1960 |
| Ms. Bonnie Handke M.B.A., R.N. | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics | -- | -- | -- |
CVRx, Inc.
9201 West Broadway Avenue
Suite 650
Minneapolis, MN 55445
United States
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 206
Description
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Corporate Governance
CVRx, Inc.’s ISS Governance QualityScore as of May 1, 2025 is 10. The pillar scores are Audit: 7; Board: 10; Shareholder Rights: 8; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
July 28, 2025 at 8:00 PM UTC - August 1, 2025 at 8:00 PM UTC
CVRx, Inc. Earnings Date
Recent Events
Related Tickers
STIM Neuronetics, Inc.
4.4300
-4.73%
IART Integra LifeSciences Holdings Corporation
12.25
-4.97%
TMCI Treace Medical Concepts, Inc.
6.82
-9.55%
TCMD Tactile Systems Technology, Inc.
9.54
-1.95%
RCEL AVITA Medical, Inc.
6.97
-25.29%
AXGN Axogen, Inc.
11.37
-9.73%
INSP Inspire Medical Systems, Inc.
151.25
-1.01%
QTRX Quanterix Corporation
5.28
-4.17%
ESTA Establishment Labs Holdings Inc.
33.92
-2.53%
VREX Varex Imaging Corporation
6.88
-20.46%